T-cell Acute Lymphoblastic Leukemia
Oncology·MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Prevalence
8.0 / 100K
Incidence
1.8 / 100K/yr
2 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Approved(2)
Frequently asked questions
How many drugs are in development for T-cell Acute Lymphoblastic Leukemia?
BioSniper tracks 2 drugs in development for T-cell Acute Lymphoblastic Leukemia across 2 companies.
How many clinical trials target T-cell Acute Lymphoblastic Leukemia?
There are 2 clinical trials targeting T-cell Acute Lymphoblastic Leukemia tracked by BioSniper.
What is the prevalence of T-cell Acute Lymphoblastic Leukemia?
The estimated prevalence of T-cell Acute Lymphoblastic Leukemia is approximately 8.0 per 100,000 population.
Deep-dive into T-cell Acute Lymphoblastic Leukemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis